|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0030705,
umls-concept:C0035820,
umls-concept:C0153453,
umls-concept:C0205101,
umls-concept:C0238019,
umls-concept:C0332293,
umls-concept:C0442115,
umls-concept:C0936012,
umls-concept:C1273870,
umls-concept:C1522449,
umls-concept:C1707491,
umls-concept:C2347880
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1996-4-23
|
|
pubmed:abstractText |
To determine the feasibility of high dose radiotherapy and to evaluate its role in the management of extrahepatic bile duct (EHBD) cancer.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
767-74
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8598352-Adult,
pubmed-meshheading:8598352-Aged,
pubmed-meshheading:8598352-Aged, 80 and over,
pubmed-meshheading:8598352-Bile Duct Diseases,
pubmed-meshheading:8598352-Bile Duct Neoplasms,
pubmed-meshheading:8598352-Bile Ducts,
pubmed-meshheading:8598352-Bile Ducts, Extrahepatic,
pubmed-meshheading:8598352-Brachytherapy,
pubmed-meshheading:8598352-Cause of Death,
pubmed-meshheading:8598352-Combined Modality Therapy,
pubmed-meshheading:8598352-Dose-Response Relationship, Radiation,
pubmed-meshheading:8598352-Feasibility Studies,
pubmed-meshheading:8598352-Female,
pubmed-meshheading:8598352-Gastrointestinal Hemorrhage,
pubmed-meshheading:8598352-Hemorrhage,
pubmed-meshheading:8598352-Humans,
pubmed-meshheading:8598352-Iridium Radioisotopes,
pubmed-meshheading:8598352-Male,
pubmed-meshheading:8598352-Middle Aged,
pubmed-meshheading:8598352-Radiotherapy Dosage,
pubmed-meshheading:8598352-Survival Analysis
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy.
|
|
pubmed:affiliation |
Division of Radiation Medicine, Research Center of Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
